The stock plunged 10.80 per cent to hit a 52-week low of Rs 868.25. At this price, it has tumbled 28.63 per cent in two ...

Natco Pharma shares nosedived today. Its results were impacted by a sharp decline in the export formulation business.

NATCO Pharma share price on Friday slumped another 10 percent after weak earnings for the third quarter of the current fiscal. The shares of the company declined 20 percent a day earlier on Thursday.

Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of ...

NATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by Nuvama. Profit fell 37.75% YoY, impacted by lower formulations exports and ...

Natco Pharma's Q3 earnings were heavily dented by a sharp drag in its export formulations segment, which accounted for 44 ...

Natco Pharma reported a net profit of Rs 132.4 crore for Q3 FY25, down 37.75% YoY compared to Rs 212.7 crore in the same ...

Image Source : PIXABAY The counter opened gap down with a loss of 18.96 per cent.

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

Revenue decreased by 37.41% YoY & profit decreased by 37.47% YoY, profit at ₹133 crore and revenue at ₹474.8 crore.

NATCO Pharma reported a 37.75% decline in Q3 FY2025 net profit, dropping to ₹132.4 crore due to a downturn in formulation ...